- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 50/10 - Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creationParticular methods of cleavage from the liquid support involving encoding steps
Patent holdings for IPC class C40B 50/10
Total number of patents in this class: 34
10-year publication summary
4
|
5
|
5
|
7
|
4
|
1
|
0
|
1
|
1
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
University of Washington | 2326 |
3 |
Illumina, Inc. | 3352 |
2 |
Massachusetts Institute of Technology | 10057 |
1 |
The Board of Trustees of the Leland Stanford Junior University | 6408 |
1 |
President and Fellows of Harvard College | 5976 |
1 |
Asahi Kasei Pharma Corporation | 135 |
1 |
Astellas Pharma Inc. | 1088 |
1 |
BioInventors & Entrepreneurs Network, LLC | 17 |
1 |
The Broad Institute, Inc. | 1808 |
1 |
Daiichi Sankyo Company, Limited | 1869 |
1 |
Fred Hutchinson Cancer Research Center | 356 |
1 |
HitGen LTD. | 19 |
1 |
Kissei Pharmaceutical Co., Ltd. | 183 |
1 |
KYORIN Pharmaceutical Co., Ltd. | 167 |
1 |
MedImmune Limited | 617 |
1 |
Mitsubishi Tanabe Pharma Corporation | 579 |
1 |
Nippon Shinyaku Co., Ltd. | 325 |
1 |
Philochem AG | 29 |
1 |
St. Jude Children's Research Hospital, Inc. | 217 |
1 |
Teijin Pharma Limited | 261 |
1 |
Other owners | 11 |